Immuneering Corporation (IMRX)
- Previous Close
2.6100 - Open
2.6000 - Bid 2.6600 x 100
- Ask 2.7300 x 100
- Day's Range
2.4500 - 2.7600 - 52 Week Range
1.0000 - 8.8900 - Volume
1,023,735 - Avg. Volume
6,332,630 - Market Cap (intraday)
80.509M - Beta (5Y Monthly) -0.61
- PE Ratio (TTM)
-- - EPS (TTM)
-1.9000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
11.21
Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 is in Investigational New Drug application to treat solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.
immuneering.comRecent News: IMRX
View More
Performance Overview: IMRX
Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IMRX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IMRX
View MoreValuation Measures
Market Cap
77.99M
Enterprise Value
22.57M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
1.18
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-37.42%
Return on Equity (ttm)
-61.81%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-56.07M
Diluted EPS (ttm)
-1.9000
Balance Sheet and Cash Flow
Total Cash (mrq)
59.73M
Total Debt/Equity (mrq)
6.50%
Levered Free Cash Flow (ttm)
-31.61M
Research Analysis: IMRX
View MoreCompany Insights: IMRX
IMRX does not have Company Insights
Research Reports: IMRX
View MoreDaily – Vickers Top Insider Picks for 06/18/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 06/17/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 06/14/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Insider Picks for 06/13/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.